Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Pharmaceutical Industry Research News Monitoring

Get by Email • RSS

Published on 16:02 GMT

Research Shows Pseudoexfoliation May Accurately Predict Glaucoma

A recent cross-sectional study conducted in Portugal revealed that pseudoexfoliation (PEX) syndrome and the ensuing thickness reduction of ganglion cell layer (GCL) and inner plexiform layer (IPL) could be used to predict glaucoma. PEX is a known risk of …

Source: Consultant Live - Pending
Published on 14:02 GMT

Pharma manufacturing 'boom' faces high costs, potential delays

With more than $270 billion in commitments to date, a new wave of pharmaceutical manufacturing is slated to hit the US. At least, that’s what the industry is trying to project. Take Johnson & Johnson's (JNJ) $55 billion over the next four years, …

Source: Yahoo Finance - Center-left
Published on 15:51 GMT

Researcher cracks code of livestock pain relief

Rafael Garcia Kansas State University No words are needed in the language of pain. "Ow" and "ah" are universally understood, as are a yelp or a cry. A grimace or a rubbed hand over a sore spot or ache convey a similar message. But like …

Source: Midwest Marketer - Iowa - Pending
Published on 16:08 GMT

Indonesia seeks Swiss investment in health, pharma sectors

Jakarta (ANTARA) - Indonesia is seeking to strengthen its strategic partnership with Switzerland, particularly in the fields of health technology and pharmaceuticals. This message was conveyed by Indonesian Ambassador to Switzerland Ngurah Swajaya at the …

Source: Antara - Pro-Government
Published on 14:38 GMT

Helensburgh Cancer Research shop to move to new location

The shop will relocate to 47 Sinclair Street, the site of the former Boots pharmacy. It shut down in 2023 and has been lying empty ever since. An opening date for the new premises is yet to be confirmed, but it is hoped the store will launch at the end of …

Source: Helensburgh Advertiser - Pending
Published on 05:50 GMT

Stocks to Watch for June 16: Vedanta, Sun Pharma, Syngene, Nazara Technologies, ITC and more

Sun Pharma | Sun Pharma confirmed a US FDA inspection at its Halol facility from June 2–13, which ended with the regulator issuing a Form 483 carrying eight observations. The site is already under an import alert following a 2022 warning letter. Halol is …

Source: CNBC-TV18 - Center-left
Published on 03:05 GMT

Does Cannabis Research Deserve As Much Funding As Ibogaine Research?

By Halle Tarvin, MA, MS While waves of change diffused across psychedelic science and research policy in Texas, bills such as Senate Bill (SB) 3 made cannabis research and medical cannabis access infinitely more difficult when it had already been a slog. I …

Source: Psychedelics Today - Neutral
Published on 04:38 GMT

Hormone behind women having greater preference for sweets than men: Japan researchers

Christmas cakes are seen in this file photo. (Mainichi/Koichiro Tezuka) NARA -- A group of researchers at Nara Women's University in this west Japan city has discovered that estrogen, a female hormone, is responsible for boosting women's …

Source: The Mainichi - Neutral
Published on 03:52 GMT

Customer-Centric Approach: How PSP Leads Georgian Pharmaceutical Market

In a remarkable journey spanning just three decades, Georgian pharmaceutical company PSP has firmly established itself as a leader in customer-oriented services within the healthcare sector. Founded during a critical time of medicine shortages, PSP has …

Source: The FINANCIAL - Pending
Published on Jun 14, 2025

Sri Lanka’s largest pharmaceutical facility to transform local healthcare industry

33 Sri Lanka is on the brink of a transformative leap in its healthcare and pharmaceutical sectors with the construction of the country’s largest pharmaceutical manufacturing facility now nearing completion. The state-of-the-art project, spearheaded by …

Source: Sunday Observer - Pro-Government
Published on Jun 14, 2025

From Patient to Researcher: It’s Not All About the Cure

For many childhood cancer survivors, the memory of treatment — vertigo, exhaustion, pain — overshadows the disease itself. While today’s therapies can be effective, they often come at a devastating cost to quality of life. In this piece, I share how …

Source: Cure Today - Neutral
Published on Jun 14, 2025

Pharmacy Industry Transitions From Traditional Dispensing to Clinical Services

In an era of evolving health care delivery, pharmacists are rapidly transitioning from traditional medication dispensing to becoming integral clinical health care providers. The Total Pharmacy Solutions Summit featured Stephanie Downing, MBA, senior …

Source: Total Pharmacy - Pending
Published on Jun 14, 2025

How remote retinal imaging raises the bar across service, research and education

The International SPECTRALIS Symposium (ISS) concluded the first day of its scientific programme with a keynote lecture about performing retinal imaging on astronauts in-orbit. The theme of remote care, and especially remote imaging, continues into the …

Source: Ophthalmology Times Europe - Pending
Published on Jun 14, 2025

Belgian Pharma Giant With Atlanta Base to Invest Billions in U.S. Factory

A Belgian pharmaceutical company with its American base in Atlanta is teasing a transformative factory for biologics in the United States. It’s yet unclear, however, how much of its suggested $5 billion impact will land in the metro area. UCB, which …

Source: Global Atlanta - Georgia - Neutral
Published on Jun 14, 2025

Can India resurface on Big Pharma clinical map?

Mumbai: As Big Pharma maps newer clinical routes to overcome the soaring development costs, regional disparities, and recruitment challenges, India stands as strategic choice—offering speed, scale, and diversity that fewer markets can match. However, …

Source: ETPharma.com - Pending
Published on Jun 14, 2025

Ending the ‘Pill Penalty’ Costly for CMS and Medicare Beneficiaries, Say Harvard Researchers

The Inflation Reduction Act (IRA) exempts biologics from CMS price negotiation for 13 years and small molecules for nine. The pharmaceutical industry has been pushing for a change that would give small molecules and biologics the same 13-year exemption. A …

Source: Managed Healthcare Executive - Neutral
Published on Jun 14, 2025

Juvena Therapeutics & Eli Lilly and Company ink research collaboration focused on muscle health

Juvena Therapeutics, Inc. (Juvena), a platform-driven clinical-stage company unlocking the therapeutic potential of stem-cell secreted proteins and translating them into a growing pipeline of engineered biologics for chronic muscle and metabolic diseases, …

Source: Pharmabiz.com - Neutral
Published on 13:48 GMT

Single-dose psilocybin therapy shows promise for reducing alcohol consumption

A new study published in the Journal of Psychopharmacology suggests that a single high dose of psilocybin, combined with psychological support, can lead to reductions in alcohol use among people with severe alcohol use disorder. In this small open-label …

Source: PsyPost - Neutral
Published on 15:14 GMT

Attacking Food Allergies: How Technology can Ease the Path to New Treatments Without the Pain

Food allergies affect an estimated 220 million people around the world, the World Health Organization reports. In the United States alone, one in 13 children are living with life-threatening food allergies, according to the non-profit organization Food …

Source: MedCity News - Neutral

16 days 16:21:11

Featured Releases

Got News to Share? · Submit · See All

Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 14:33 GMT

WST 重要截止日期：全美審訊法律顧問 ROSEN 鼓勵損失 10 萬美元以上的 West Pharmaceutical Services, Inc. 投資者在對 WST 提出證券集體訴訟的重要截止日期前聘請律師

紐約, June 15, 2025 (GLOBE NEWSWIRE) -- 事因：全球投資者權益律師事務所 Rosen Law Firm 提醒在 2023 年 2 月 16 日至 2025 年 2 月 12 日（包括首尾兩日，下稱「集體訴訟期」）期間購買了 West Pharmaceutical Services, Inc. (NYSE: WST) 普通股之人士注意，重要的首席原告截止日期為 2025 年 7 月 7 日。影響：如果您在集體訴訟期間購買 West …

Distribution channels: Consumer Goods, Law ...

Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UroGen Pharma Ltd. of Class ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

Distribution channels: Consumer Goods, Law ...

Published on June 15, 2025 - 14:33 GMT

WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive ( …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 15:22 GMT

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal ...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study New late-breaking data at EAACI showed Dupixent …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 15:22 GMT

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes ...

EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 12:06 GMT

Redefining Fabry Disease Care: Gene Therapy and Long-Acting ERT Prepare to Disrupt Status Quo | Competitive Intellignece

Fabry disease treatment is advancing rapidly with gene therapies and next-gen ERTs promising durable efficacy, reduced burden, and broader mutation coverage. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Fabry Disease, a rare, X …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 822,453,890 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 15, 2025 - 12:13 GMT

Mindworks NLP Offers a Smoking Cessation Group Hypnosis Live Event in Bellevue – June 21

Mindworks NLP announces a public group hypnosis seminar on June 21 to help participants quit smoking using powerful subconscious change techniques. BELLEVUE, WA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- In a time when public health and …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 15, 2025 - 12:06 GMT

Redefining Fabry Disease Care: Gene Therapy and Long-Acting ERT Prepare to Disrupt Status Quo | Competitive Intellignece

Fabry disease treatment is advancing rapidly with gene therapies and next-gen ERTs promising durable efficacy, reduced burden, and broader mutation coverage. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Fabry Disease, a rare, X …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:06 GMT

Hunter Syndrome Therapeutics Evolve: Novel CNS-Targeting Therapies Set to Challenge Elaprase’s Market Monopoly

New CNS-penetrant therapies and gene therapies are poised to transform the Hunter Syndrome landscape, ending Elaprase’s long-standing treatment dominance. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Hunter Syndrome ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:06 GMT

Rewriting the Playbook in MPS I: CNS-Penetrant ERTs and Gene Therapies Usher in a New Treatment Era | CI Insights

Emerging CNS‑targeting ERTs and gene therapies for MPS I show promise for neurocognitive benefits, reduced treatment burden, and better outcomes. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Mucopolysaccharidosis type I (MPS I) …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 04:30 GMT

Thorncrest Dental Brings Advanced Laser Dentistry to Etobicoke with Picasso Soft Tissue Laser

ETOBICOKE, ONTARIO, CANADA, June 15, 2025 /⁨EINPresswire.com⁩/ -- Thorncrest Dental is proud to introduce the Picasso Soft Tissue Laser, a cutting-edge addition to its suite of dental technologies, now available to patients in the Etobicoke community. This …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 15:22 GMT

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes ...

EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 15:22 GMT

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal ...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study New late-breaking data at EAACI showed Dupixent …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 15:21 GMT

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (...

New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints Dupixent also outperformed Xolair in improving such key signs and symptoms as nasal polyp …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 03:00 GMT

Tom Jackobs Offers Fractional Sales Management for Heart-Led Wellness Practices

New service helps mission-driven businesses improve sales performance without building a full in-house sales team. LOS ANGELES, CA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Tom Jackobs, international sales strategist, is now offering …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on June 15, 2025 - 14:45 GMT

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in ...

With up to three years of follow-up, a single dose of lonvo-z led to a 98% mean reduction in monthly HAE attack rate in all 10 patients All 10 patients were attack-free and treatment-free for a median of 23 months through the latest follow-up, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:00 GMT

New national report reveals critical gaps in asthma and COPD care

A new NRAP report has highlighted persistent and widespread gaps in the care of people with asthma and chronic obstructive pulmonary disease (COPD) across England and Wales, calling on integrated care boards and local health boards to mandate all eligible …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 12:00 GMT

RCP statement on Air India crash

RCP president, Dr Mumtaz Patel, said: ‘We are devastated by the plane crash in India today and the many lives it has claimed. Our thoughts and prayers are with everyone affected by this tragic incident. ‘We are directly contacting all our RCP members in …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 12:00 GMT

Latest ‘Focus on physicians’ survey closes with over 2000 responses from doctors across the UK

The 2025 ‘Focus on physicians’ survey – a joint project between the Royal College of Physicians (RCP), the Royal College of Physicians and Surgeons of Glasgow (RCPSG) and the Royal College of Physicians of Edinburgh (RCPE) – has now closed. The ‘Focus on …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 11:45 GMT

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP ...

– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for greater potency with verekitug compared to tezepelumab – – Supports potentially differentiated profile of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on June 15, 2025 - 11:11 GMT

D-Bal Max 2025: Exploring the Science and Safety behind a Popular And Legal Dianabol Steroid For Muscle Growth

Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced athletic performance and muscle growth, many fitness enthusiasts and bodybuilders turn to supplements. D-Bal Max has emerged as a noteworthy option that claims to replicate the muscle- …

Distribution channels:
Published on June 14, 2025 - 16:42 GMT

Blue Sky Scrubs Celebrates World Wind Day: Championing Clean Energy for a Healthier Planet

Blue Sky Medical Scrubs and Scrub Caps Celebrates World Wind Day: Championing Clean Energy for a Healthier Planet AUSTIN, TX, UNITED STATES, June 14, 2025 /⁨EINPresswire.com⁩/ -- In celebration of World Wind Day, Blue Sky Scrubs proudly joins the …

Distribution channels: Culture, Society & Lifestyle, Environment ...
Published on June 14, 2025 - 16:38 GMT

Cherry Blossoms and The Other Side, A Poetic Journey Through Grief and Beyond

LAWRENCE, MA, UNITED STATES, June 14, 2025 /⁨EINPresswire.com⁩/ -- Acclaimed writer and visual dramatist Dennis Mullings presents a powerful double release with Cherry Blossoms and The Other Side, two moving and visually arresting plays that navigate the …

Distribution channels: Book Publishing Industry, Culture, Society & Lifestyle ...
Published on June 14, 2025 - 16:28 GMT

ICN elects new President, José Luis Cobos Serrano and a new Board of Directors

ICN announces Dr José Luis Cobos Serrano as its 30th President at its Congress in Helsinki HELSINKI, FINLAND, June 14, 2025 /⁨EINPresswire.com⁩/ -- At the closing ceremony of ICN Congress 2025, ICN announced that it has elected Dr José Luis Cobos …

Distribution channels: Healthcare & Pharmaceuticals Industry, Human Rights ...
Published on June 14, 2025 - 14:48 GMT

Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in ...

77% of patients (150 mg Q4W) treated with barzolvolimab who had angioedema at baseline were angioedema free at Week 52 Data further support barzolvolimab clinical benefit to patients with CSU HAMPTON, N.J., June 14, 2025 (GLOBE NEWSWIRE) -- Celldex …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 14, 2025 - 14:42 GMT

ThinkCareBelieve: Week 21 of America's Progress under President Trump

Washington D.C., June 14, 2025 (GLOBE NEWSWIRE) -- You can find the article here: https://thinkcarebelieve.blog/2025/06/14/week-21-of-americas-progress-under-president-trump/ ThinkCareBelieve has published an article on the …

Distribution channels: Book Publishing Industry, Healthcare & Pharmaceuticals Industry ...